Eosinophil ribonucleases and their cutaneous lesion-forming activity

Journal of Immunology

Volumn 183, Issue 6, 2009, Pages 4013-4020

  Plager, Douglas A ^a   Davis, Mark D P ^a   Andrews, Amy G ^a   Coenen, Michael J ^a   George, Terry J ^a   Gleich, Gerald J ^a,b   Leiferman, Kristin M ^a,c  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATION; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL GRANULE PROTEIN; EOSINOPHIL PEROXIDASE; EOSINOPHIL PROTEIN X; RIBONUCLEASE; MAJOR BASIC PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; EOSINOPHIL; ERYTHEMA; GLYCOSYLATION; HUMAN; HUMAN TISSUE; HYPEREOSINOPHILIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; RABBIT; SKIN; SKIN DEFECT; SKIN INFLAMMATION; SKIN ULCER; SWINE; ANIMAL; ENZYMOLOGY; EOSINOPHILIA; GUINEA PIG; PATHOLOGY; SKIN DISEASE; ULCER;

ANIMALS; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL GRANULE PROTEINS; EOSINOPHIL MAJOR BASIC PROTEIN; EOSINOPHIL PEROXIDASE; EOSINOPHIL-DERIVED NEUROTOXIN; EOSINOPHILIA; EOSINOPHILS; GUINEA PIGS; HUMANS; RABBITS; RIBONUCLEASES; SKIN DISEASES; ULCER;

EID: 70349303955     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900055     Document Type: Article

References (50)

1. Kita, H., C. R. Adolphson, and G. J. Gleich. 2003. Biology of Eosinophils. In Allergy: Principles and Practice, 6th Ed. N. F. Adkinson, Jr., J. W. Yunginger, W. W. Busse, B. S. Bochner, S. T. Holgate, and F. E. R. Simons, eds. Mosby, Philadelphia, pp. 305-332.
2. Plager, D. A., D. A. Loegering, D. A. Weiler, J. L. Checkel, J. M. Wagner, N. J. Clarke, S. Naylor, S. M. Page, L. L. Thomas, I. Akerblom, et al. 1999. A novel and highly divergent homolog of human eosinophil granule major basic protein. J. Biol. Chem. 274: 14464-14473.
3. Abu-Ghazaleh, R. I., S. L. Dunnette, D. A. Loegering, J. L. Checkel, H. Kita, L. L. Thomas, and G. J. Gleich. 1992. Eosinophil granule proteins in peripheral blood granulocytes. J. Leukocyte Biol. 52: 611-618.
4. Leiferman KM, P. M. 2006. Eosinophils in cutaneous diseases. In Fitzpatrick's Dermatology in General Medicine, 7th Ed. K. Wolff, L. A. Goldsmith, S. I. Katz, B. A. Gilchrest, A. S. Paller, and D. J. Leffell, eds. McGraw-Hill Medical, New York, pp. 307-317.
5. Davis, M. D., D. A. Plager, T. J. George, E. A. Weiss, G. J. Gleich, and K. M. Leiferman. 2003. Interactions of eosinophil granule proteins with skin: limits of detection, persistence, and vasopermeabilization. J. Allergy Clin. Immunol. 112: 988-994.
6. Leiferman, K. M., S. J. Ackerman, H. A. Sampson, H. S. Haugen, P. Y. Venencie, and G. J. Gleich. 1985. Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis: comparison with onchocerciasis. N. Engl. J. Med. 313: 282-285.
7. Ott, N. L., G. J. Gleich, E. A. Peterson, T. Fujisawa, S. Sur, and K. M. Leiferman. 1994. Assessment of eosinophil and neutrophil participation in atopic dermatitis: comparison with the IgE-mediated late-phase reaction. J. Allergy Clin. Immunol. 94: 120-128.
8. Cheng, J. F., N. L. Ott, E. A. Peterson, T. J. George, M. J. Hukee, G. J. Gleich, and K. M. Leiferman. 1997. Dermal eosinophils in atopic dermatitis undergo cytolytic degeneration. J. Allergy Clin. Immunol. 99: 683-692.
9. Specht, S., M. Saeftel, M. Arndt, E. Endl, B. Dubben, N. A. Lee, J. J. Lee, and A. Hoerauf. 2006. Lack of eosinophil peroxidase or major basic protein impairs defense against murine filarial infection. Infect. Immun. 74: 5236-5243. (Pubitemid 44300442)
10. Rosenberg, H. F., and J. B. Domachowske. 2001. Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens. J. Leukocyte Biol. 70: 691-698.
11. Abu-Ghazaleh, R. I., G. J. Gleich, and F. G. Prendergast. 1992. Interaction of eosinophil granule major basic protein with synthetic lipid bilayers: a mechanism for toxicity. J Membr. Biol. 128: 153-164.
12. Kroegel, C., U. Costabel, and H. Matthys. 1987. Mechanism of membrane damage mediated by eosinophil major basic protein. Lancet 1: 1380-1381.
13. Swaminathan, G. J., A. J. Weaver, D. A. Loegering, J. L. Checkel, D. D. Leonidas, G. J. Gleich, and K. R. Acharya. 2001. Crystal structure of the eosinophil major basic protein at 1.8 Å: an atypical lectin with a paradigm shift in specificity. J. Biol. Chem. 276: 26197-26203.
14. Gleich, G. J., D. A. Loegering, M. P. Bell, J. L. Checkel, S. J. Ackerman, and D. J. McKean. 1986. Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. Proc. Natl. Acad. Sci. USA 83: 3146-3150. (Pubitemid 16042993)
15. Sorrentino, S., D. G. Glitz, K. J. Hamann, D. A. Loegering, J. L. Checkel, and G. J. Gleich. 1992. Eosinophil-derived neurotoxin and human liver ribonuclease: identity of structure and linkage of neurotoxicity to nuclease activity. J. Biol. Chem. 267: 14859-14865.
16. Piliponsky, A. M., G. J. Gleich, A. Nagler, I. Bar, and F. Levi-Schaffer. 2003. Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor. Blood 101: 1898-1904.
17. Thomas, L. L., L. M. Zheutlin, and G. J. Gleich. 1989. Pharmacological control of human basophil histamine release stimulated by eosinophil granule major basic protein. Immunology 66: 611-615.
18. Kita, H., R. I. Abu-Ghazaleh, S. Sur, and G. J. Gleich. 1995. Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils. J. Immunol. 154: 4749-4758.
19. Gleich, G. J., A. L. Schroeter, J. P. Marcoux, M. I. Sachs, E. J. O'Connell, and P. F. Kohler. 1984. Episodic angioedema associated with eosinophilia. N. Engl. J. Med. 310: 1621-1626.
20. Leiferman, K. M., D. A. Loegering, G. J. Gleich. 1984. Production of wheal-and-flare skin reactions by eosinophil granule proteins. J. Invest. Dermatol. 82: 414 (Abstr.).
21. Flood-Page, P. T., A. N. Menzies-Gow, A. B. Kay, and D. S. Robinson. 2003. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am. J. Respir. Crit. Care Med. 167: 199-204.
22. Phipps, S., P. Flood-Page, A. Menzies-Gow, Y. E. Ong, and A. B. Kay. 2004. Intravenous anti-IL-5 monoclonal antibody reduces eosinophils and tenascin deposition in allergen-challenged human atopic skin. J. Invest. Dermatol. 122: 1406-1412. (Pubitemid 38757222)
23. Rothenberg, M. E., and S. P. Hogan. 2006. The eosinophil. Annu. Rev. Immunol. 24: 147-174.
24. Kondo, N., S. Shinoda, O. Fukutomi, H. Agata, T. Terada, H. Shikano, A. M. Montano, H. Sakaguchi, M. Watanabe, K. Komiyama, et al. 2000. Eosinophils are neither migrated nor activated in the skin lesions of atopic dermatitis in infants. J. Investig. Allergol. Clin. Immunol. 10: 11-13. (Pubitemid 30189453)
25. Pineda, A. A., S. M. Brzica, Jr., and H. F. Taswell. 1977. Continuous- and semicontinuous-flow blood centrifugation systems: therapeutic applications, with plasma-, platelet, lympha-, and eosinapheresis. Transfusion 17: 407-416.
26. Gleich, G. J., D. A. Loegering, K. G. Mann, and J. E. Maldonado. 1976. Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils. J. Clin. Invest. 57: 633-640.
27. Slifman, N. R., D. A. Loegering, D. J. McKean, and G. J. Gleich. 1986. Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein. J. Immunol. 137: 2913-2917.
28. Carlson, M. G., C. G. Peterson, and P. Venge. 1985. Human eosinophil peroxidase: purification and characterization. J. Immunol. 134: 1875-1879. (Pubitemid 15128954)
29. Plager, D. A., D. A. Loegering, J. L. Checkel, J. Tang, G. M. Kephart, P. L. Caffes, C. R. Adolphson, L. E. Ohnuki, and G. J. Gleich. 2006. Major basic protein homolog (MBP2): a specific human eosinophil marker. J. Immunol. 177: 7340-7345.
30. Johnston, N. W., and J. Bienenstock. 1974. Abolition of non-specific fluorescent staining of eosinophils. J. Immunol. Methods 4: 189-194.
31. Krenik, K. D., G. M. Kephart, K. P. Offord, S. L. Dunnette, and G. J. Gleich. 1989. Comparison of antifading agents used in immunofluorescence. J. Immunol. Methods 117: 91-97.
32. Ogura, M., and M. Mitsuhashi. 1995. Fluorometric method for the measurement of nuclease activity on plastic plates. Biotechniques 18: 231-233.
33. Leiferman, K. M., J. D. O'Duffy, H. O. Perry, P. R. Greipp, E. R. Giuliani, and G. J. Gleich. 1982. Recurrent incapacitating mucosal ulcerations: a prodrome of the hypereosinophilic syndrome. J. Am. Med. Assoc. 247: 1018-1020.
34. Leiferman, K. M., G. J. Gleich, and M. S. Peters. 2007. Dermatologic manifestations of the hypereosinophilic syndromes. Immunol. Allergy Clin. North Am. 27: 415-441.
35. Leiferman, K. M., D. A. Plager, and G. J. Gleich. 2002. Eosinophils and atopic dermatitis. In Atopic Dermatitis. T. Bieber and D. Y. M. Leung, eds. Dekker, New York, pp. 327-355.
36. Leiferman, K. M., M. S. Peters, D. A. Plager, and G. J. Gleich, 2009. Eosinophils. In Atopic Dermatitis, 2nd ed. T. Bieber and D. Y. M. Leung, eds. Dekker, New York. In Press.
37. Wu, Y., S. M. Mikulski, W. Ardelt, S. M. Rybak, and R. J. Youle. 1993. A cytotoxic ribonuclease: study of the mechanism of onconase cytotoxicity. J. Biol. Chem. 268: 10686-10693. (Pubitemid 23150262)
38. Wu, Y., S. K. Saxena, W. Ardelt, M. Gadina, S. M. Mikulski, C. De Lorenzo, G. D'Alessio, and R. J. Youle. 1995. A study of the intracellular routing of cytotoxic ribonucleases. J. Biol. Chem. 270: 17476-17481.
39. Maeda, K., K. Yamamoto, Y. Tanaka, S. Anan, and H. Yoshida. 1992. The relationship between eosinophils, OKT6-positive cells and house dust mite (HDM) antigens in naturally occurring lesions of atopic dermatitis. J. Dermatol. Sci. 3: 151-156.
40. Yang, D., Q. Chen, S. B. Su, P. Zhang, K. Kurosaka, R. R. Caspi, S. M. Michalek, H. F. Rosenberg, N. Zhang, and J. J. Oppenheim. 2008. Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses. J. Exp. Med. 205: 79-90.
41. Triantafilou, M., M. Manukyan, A. Mackie, S. Morath, T. Hartung, H. Heine, and K. Triantafilou. 2004. Lipoteichoic acid and Toll-like receptor 2 internalization and targeting to the Golgi are lipid raft-dependent. J. Biol. Chem. 279: 40882-40889.
42. Yang, D., A. Biragyn, D. M. Hoover, J. Lubkowski, and J. J. Oppenheim. 2004. Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu. Rev. Immunol. 22: 181-215.
43. Groves, R. W., M. H. Allen, E. L. Ross, J. N. Barker, and D. M. MacDonald. 1995. Tumour necrosis factor α is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression. Br. J. Dermatol. 132: 345-352.
44. Rampart, M., W. De Smet, W. Fiers, and A. G. Herman. 1989. Inflammatory properties of recombinant tumor necrosis factor in rabbit skin in vivo. J. Exp. Med. 169: 2227-2232. (Pubitemid 19162979)
45. Futami, J., T. Maeda, M. Kitazoe, E. Nukui, H. Tada, M. Seno, M. Kosaka, and H. Yamada. 2001. Preparation of potent cytotoxic ribonucleases by cationization: enhanced cellular uptake and decreased interaction with ribonuclease inhibitor by chemical modification of carboxyl groups. Biochemistry 40: 7518-7524. (Pubitemid 32578016)
46. Eriksson, J., C. Woschnagg, E. Fernvik, and P. Venge. 2007. A SELDI-TOF MS study of the genetic and post-translational molecular heterogeneity of eosinophil cationic protein. J. Leukocyte Biol. 82: 1491-1500. (Pubitemid 350276961)
47. Cho, S., J. J. Beintema, and J. Zhang. 2005. The ribonuclease A superfamily of mammals and birds: identifying new members and tracing evolutionary histories. Genomics 85: 208-220. (Pubitemid 40164786)
48. Domachowske, J. B., K. D. Dyer, A. G. Adams, T. L. Leto, and H. F. Rosenberg. 1998. Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity. Nucleic Acids Res. 26: 3358-3363.
49. Gleich, G. J., K. M. Leiferman, A. Pardanani, A. Tefferi, and J. H. Butterfield. 2002. Treatment of hypereosinophilic syndrome with imatinib mesilate. Lancet 359: 1577-1578.
50. Leiferman, K. M., and G. J. Gleich. 2004. Hypereosinophilic syndrome: case presentation and update. J. Allergy Clin. Immunol. 113: 50-58. (Pubitemid 38096161)